NNP
EW icon

Nachman Norwood & Parrott’s Edwards Lifesciences EW Stock Holding History

Nachman Norwood & Parrott’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,479
Closed -$118K – 498
2020
Q3 		$118K Buy
+1,479
New +$115K 0.02% 312
2020
Q1 		– Sell
-2,679
Closed -$208K – 229
2019
Q4 		$208K Buy
+2,679
New +$209K 0.03% 237

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Nachman Norwood & Parrott's EW Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 1,479 shares — an estimated $118K sold.

Nachman Norwood & Parrott first reported a position in EW in Q4 2019 and held it in 2 quarters. The position peaked at $208K in Q4 2019. 1,158 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 1,479 Edwards Lifesciences shares in Q4 2020, an estimated $118K.
  • Nachman Norwood & Parrott first reported a position in Edwards Lifesciences in Q4 2019 and held it in 2 quarters.
  • Nachman Norwood & Parrott's Edwards Lifesciences position peaked at $208K in Q4 2019.
  • 1,158 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.